CSE: AIAI | OTCQB: AINMF | FRA: PF0

The MidDayBell: How NetraMark’s Explainable AI Could Transform Clinical Trials

George Achilleos, CEO of NetraMark, and Dr. Luca Pani, Chief Innovation & Regulatory Officer, discuss NetraMark’s explainable AI, model-derived subpopulations, a collaboration with NIMH, onboarding with Worldwide Clinical Trials, and an upcoming FDA Critical Path Innovation Meeting.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.